Prolonged inhibition of IgE production in mice following treatment with an IgE-specific immunotoxin

Molecular Immunology

Volumn 33, Issue 3, 1996, Pages 245-251

  Lustgarten, Joseph ^a,b   Waks, Tova ^a   Eshhar, Zelig ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Immunotoxin; ITA

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTOXIN; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; RICIN A;

ALLERGY; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; IMMUNOGLOBULIN PRODUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0029886208     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(95)00141-7     Document Type: Article

References (28)

1. Baniyash M., Kehry M. and Eshhar Z. (1988) Anti-IgE monoclonal antibodies directed at the Fc α receptor binding site. Molec. Immun. 25, 705-711.
2. Baniyash M., Eshhar Z. and Rivnay B. (1986) Relationships between epitopes on IgE recognized by defined monoclonal antibodies and by the Fc receptor on basophils. J. Immun. 136, 588-593.
3. Bending M. M. (1995) Humanization of rodent monoclonal antibodies by CDR grafting. Immunomethods 8, 83-93.
4. Chang T. W., Davis F. M., Sun N.-C., Sun C. R. Y., MacGlashan Jr D. W. and Hamilton R. G. (1990) Monoclonal antibodies specific for IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases. Biotechnology 8, 122-126.
5. Coffman R. L., Ohara J., Bond M. W., Carty J., Zlotnick A. and Paul W. E. (1986) B cell stimulating factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immun. 136, 4538-4541.
6. Davis F. M., Gosset L. A. and Chang T. W. (1991) An epitope on membrane-bound but not secreted IgE: implications in isotype-specific regulation. Biotechnology 9, 53-56.
7. Diaz-Sanchez D. and Kemeny D. M. (1991) Generation of a long-lived IgE response in high and low responder strains of rat by co-administration of ricin and antigen. Immunology 72, 297-303.
8. Diaz-Sanchez D., Lee T. H. and Kemeny D. M. (1993) Ricin enhances IgE responses by inhibiting a subpopulation of early-activated IgE regulatory CD8+ T cells. Immunology 78, 226-236.
9. Eshhar Z., Ofarim M. and Waks T. (1980) Generation of hybridomas secreting murine reagenic antibodies of antiDNP specificity. J. Immun. 124, 775-780.
10. Geha M. S. J. (1984) Human IgE. J. Allergy clin. Immun. 74, 109-120.
11. Haak-Frendscho M., Robbins K., Lyon R., Shields R., Hooley J., Schoenhoff M. and Jardieu P. (1994) Administration of an anti-IgE antibody inhibits CD23 expression and IgE production in vivo. Immunology 82, 306-313.
12. Haba S. and Nisonoff A. (1994) Effects of syngeneic anti-IgE antibodies on the development of IgE memory and on the secondary IgE response. J. Immun. 152, 51-57.
13. Krolick K. A., Uhr J. W. and Vitetta E. S. (1983) Preparation and application of antibodies coupled to A chain of ricin. Meth. Enzymol. 93, 333-338.
14. MacKenzie T. and Dosch H. M. (1989) Clonal and molecular characteristics of the human IgE-committed B cell subset. J. exp. Med. 169, 407-430.
15. Peng C., Davis F. M., Sun L. K., Liou R. S., Kim Y. and Chang T. W. (1992) A new isoform of human membrane-bound IgE. J. Immun. 148, 129-136.
16. Purkerson J. and Isakson P. (1992) A two signal model for regulation of immunoglobulin isotype switching. FASEB J. 6, 3245-3252.
17. Reiter Y. and Fishelson Z. (1989) Killing of human tumor cells by antibody C3b conjugates and human complement. Targeted Diagn. Ther. 2, 119-135.
18. Romagnani S. (1990) Regulation and deregulation of human IgE synthesis. Immun. Today 11, 316-321.
19. Romagnani S., Damiani G., Giudizi M. G., Biagiotti R., Almerigogna F., Delprete G. F., Maggi E., Bargellesi A. and Ricci M. (1982) In vitro production of IgE by human peripheral blood mononuclear cells. III. Demonstration of a circulating IgE-bearing cell involved in the spontaneous IgE biosynthesis. Clin. exp. Immun. 49, 176-184.
20. Rybak S. M., Hoogenboom H. R., Newton D. L., Raus J. C. and Youle R. J. (1992) Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxins. Cell Biophys. 21, 121-138.
21. Saxon A., Kaplan M. and Stevens R. H. (1980) Isotype-specific human B lymphocytes that produce immunoglobulin E in vitro when stimulated by pokeweed mitogen. J. Allergy clin. Immun. 66, 233-241.
22. + T cells. A. Rev. Immun. 12, 635-673.
23. Snapper C. M. and Paul W. E. (1987) Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944-947.
24. Stampfli M. R., Miescher S., Aebischer I., Zurcher A. W. and Stadler B. M. (1994) Inhibition of human IgE synthesis by anti-IgE antibodies requires divalent recognition. Eur. J. Immun. 24, 2161-2167.
25. Suda T. and Nagata S. (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J. exp. Med. 179, 873-879.
26. Vanhove B. and Bazin H. (1992) IgG2b or IgE molecules can be co-expressed with those of the IgM and IgD isotypes of the membrane of normal rat B cells. Molec. Immun. 29, 1-8.
27. Yanagihara Y., Kajiwara K., Ikizawa K., Koshio T. and Okumura K., Ra C. (1994) Recombinant soluble form of the human high-affinity immunoglobulin E (IgE) receptor inhibits IgE production through its specific binding to IgE-bearing B cells. J. clin. Invest. 94, 2162-2165.
28. Yaoita Y., Kumagai Y., Okumura K. and Honjo T. (1982) Expression of lymphocyte surface IgE does not require switch recombination. Nature 297, 697-699.